The Novel Tetra-Specific Drug C-192, Conjugated Using UniStac, Alleviates Non-Alcoholic Steatohepatitis in an MCD Diet-Induced Mouse Model

• Päätekijät: Jihye Kim (Tekijä), Nakho Chang (Tekijä), Yunki Kim (Tekijä), Jaehyun Lee (Tekijä), Daeseok Oh (Tekijä), Jaeyoung Choi (Tekijä), Onyou Kim (Tekijä), Sujin Kim (Tekijä), Myongho Choi (Tekijä), Junyeob Lee (Tekijä), Junghwa Lee (Tekijä), Jungyul Kim (Tekijä), Minji Cho (Tekijä), Minsu Kim (Tekijä), Kwanghwan Lee (Tekijä), Dukhyun Hwang (Tekijä), Jason K. Sa (Tekijä), Sungjin Park (Tekijä), Seungjae Baek (Tekijä), Daeseong Im (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: MDPI AG, 2023-11-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Non-alcoholic steatohepatitis (NASH) is a complex disease resulting from chronic liver injury associated with obesity, type 2 diabetes, and inflammation. Recently, the importance of developing multi-target drugs as a strategy to address complex diseases such as NASH has been growing; however, their...